Scope
Description
Procurement of Revcovi, an approved enzyme replacement therapy (ERT) indicated for the treatment of adenosine deaminase severe combined immune deficiency.
Contract 1. Revcovi infusion
Supplier
Contract value
- £3,996,000 excluding VAT
- £4,795,200 including VAT
Above the relevant threshold
Earliest date the contract will be signed
3 September 2025
Contract dates (estimated)
- 3 September 2025 to 30 August 2028
- 2 years, 11 months, 28 days
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKN - Northern Ireland
Other information
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Direct award
Direct award justification
Single supplier - intellectual property or exclusive rights
As per Section 41 of the PA2023, a direct award is made in line with Schedule 5 of the PA2023 paragraph 5 "due to the supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required,"
This product is the only commercially available from one supplier and no competition or alternative exists for this product.
Supplier
CHIESI LIMITED
- Companies House: 02140985
- Public Procurement Organisation Number: PDRG-6355-YCVG
333 Styal Road
Manchester
M22 5LG
United Kingdom
Email: CustomerServices.UK@chiesi.com
Website: https://www.chiesi.uk.com/
Region: UKD33 - Manchester
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Contract 1. Revcovi infusion
Contracting authority
Southern Health and Social Care Trust
- Public Procurement Organisation Number: PJCC-1957-RCGP
Craigavon Area Hospital, 68 Lurgan Road
Portadown
BT63 5QQ
United Kingdom
Email: dac@southerntrust.hscni.net
Region: UKN07 - Armagh City, Banbridge and Craigavon
Organisation type: Public authority - central government
Devolved regulations that apply: Northern Ireland